ABSTRACT
as those who have undergone at least 1 colonoscopy and gastroscopy, but source of continuous bleeding could not be detected. [2] Angiodysplasia has been detected as most frequent source of these GI bleeds. [3] GI bleeding without obvious etiology may be either occult or overt. Overt bleeding is defined as visible GI bleeding that generally presents as melena, or hematochezia. In contrast, occult bleeding is not visible to the patient or the physician. These bleeds may be associated with iron deficiency anemia and may manifest as positive fecal blood test. [4] Debate continues on treatment of GI bleeding with no obvious etiology as result of difficulties in determining source. Capsule endoscopy (CE) is favored technique to evaluate these bleeds. [5] [6] [7] Several studies have shown high specificity and sensitivity of CE in setting of overt GI bleeding (OGIB) and reported that it has better diagnostic yield than other
INTRODUCTION
Gastrointestinal (GI) tract bleeding that persists or recurs with no obvious etiology represents approximately 5% of all cases of GI system bleeding. [1] These patients can be defined Üçüncü et al. What is the clinical yield of capsule endoscopy in the management of obscure bleeding in emergency service?
endoscopic or radiological techniques. The aim of this study was to present our experience in evaluation of patients with OGIB using CE in emergency service. 
MATERIALS AND METHODS

Statistical Analysis
Descriptive statistics were used to summarize patient demographic and clinical characteristics, endoscopic findings, and therapeutic procedures. Categorical variables were presented as percentages and numeric variables as means and ranges.
RESULTS
Thirty-eight patients who were under follow-up to identify source of GI bleeding of unknown origin in the Istanbul University Istanbul Faculty of Medicine emergency surgery department and who were screened using CE were included in this study. Twelve patients (32%) were women and 26 (68%) were men. Average age was 55.57 years (range: 20-88 years). Nine patients were using anticoagulants. Ten were followed-up in intensive care, and 7 underwent angiography. Angioembolization was performed on 1 patient who was diagnosed with CE as having active bleed. Average erythrocyte suspension replacement was 20.7 units. Thirteen patients underwent surgery for bleeding found with CE. Tumor was detected in 8 of these patients. Double-balloon endoscopy was performed in 11 patients. Of these, sclerotherapy was performed on 2 patients and cauterization was used in 5 cases. According to CE findings, 19 patients were therapeutically treated (Figure 1 ). Four patients died: 2 patients died in hospital during conservative follow-up. One patient who was undergoing therapeutic treatment died of anastomotic leakage after bowel resection and anastomosis. One patient died as result of cholangiocarcinoma recurrence ( Table 1) .
Source of bleeding was detected in 35 patients based on CE results. Source of GI bleeding was not determined based on CE evaluation in 2 patients, and CE evaluation was normal in remaining patient. Diagnostic yield was 78.9% in the present study. Capsule retention occurred in 3 patients due to small bowel adenocarcinoma and in 1 patient due to lipoma. One patient was readmitted to hospital due to multiple angiodysplasia of the small intestine. Average length of hospital stay was 32.68 days (range: 3-153 days) CE results were grouped in 4 categories: 1) active bleeding, 2) vascular lesions (angiodysplasia, erosion, ulcers, vascular ectasia), 3) mass (bulk), and 4) normal findings ( Figure 2-4 ).
Seventeen patients from conservatively managed group were not readmitted to hospital for any GI bleeding symptoms.
DISCUSSION
According to the American Gastroenterology journal guidelines issued in 2015, bleeding from small intestine was categorized into 2 main groups. If no specific source of bleeding could be identified after thorough examination, bleeding was referred to as obscure. However, overt and occult GI bleeding refers to known source, even if etiology is not initially obvious. Performance of CE has had great impact on correct categorization of suspected cases of GI bleeding. In study conducted by Pennazio et al., diagnostic value of CE in patients with occult bleeding was 92.3%, and it was 44% for overt bleeding. [8] According to some published literature, this rate may decrease to 45.7%. This may be due to length of time between bleeding occurrence and CE. Bresci et al. revealed inverse relationship between timing of CE and bleeding. The authors found higher diagnostic value in patients who underwent earlier CE. [9] It has been proposed in international consensus meetings that earliest CE performance should be within the first 2 weeks of symptom observation.
Age is a factor that improves diagnostic efficiency in determining etiological source of GI bleeding. Scaglione et al. reported that diagnostic value under the age of 65 years was 45% while ratio goes up to 75% for patients aged over 65 years. [10] 
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Different methods have been used to identify source of bleeding, such as double-balloon endoscopy, angiography, and radionuclide imaging. In addition to drawbacks of these methods, including invasiveness, sedation requirement, and radiation involvement, diagnostic value has been found to be lower when compared with CE. Angiography can detect source of bleeding with intra-arterial contrast agent, but only when intensity of bleeding is at least 0.5 mL/min. [11] Advantage of angiography is that intervention can be performed in the same session if bleeding is detected. However, it does not give us any information about nature of the lesion. Although radionuclide scanning is superior to angiography in terms of being non-invasive method and providing information about active bleeding (0.1-0.4 mL/min), no bleeding intervention can be performed with this method. Double-balloon endoscopy requires significant experience, sedation of the patient, and has lower diagnostic yield compared with CE. Kameda et al. examined diagnostic yield of double-balloon endoscopy (65%) and CE (71%). Although Lin et al. supported Kamada, diagnostic yield of double-balloon endoscopy was found to be higher than that of CE in a study conducted by Arakawa et al. [12, 13] In conclusion, CE is superior method because it is non-invasive, does not require sedation or radiation, and provides better diagnostic value. Although CE offers advantages over other methods, it also has drawbacks, such as inability to perform biopsy or therapeutic intervention, and there is risk for capsule retention. Although tomography performed prior to CE would seem to be solution in terms of preventing capsule retention, it should be noted that it is also possible that battery life may expire before capsule reaches the cecum in patients with no evidence of obstruction. Furthermore, experienced physician is needed to recognize lesions seen with CE. In our study, retention was detected in 4 patients due to presence of mass.
Intraoperative enteroscopy has been proposed as alternative method and should be preferred for evaluation in unstable situation. [14] Guidelines have begun to emerge with widespread use of CE in patients with GI bleeds and no obvious etiology. Guidelines developed by Gerson et al. are presented here as an example. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Our algorithm is shown in Figure 5 .
In the present study, after gastroscopy and colonoscopy, tomography was performed on patients with GI bleeding to determine presence of any obstruction before CE. Appropriate treatment for each patient was based on CE results. Diagnostic yield was found to be 78.9%, which is consistent with the literature. [19] Main limitations of this study include its retrospective nature and the inability to perform CE in large population due to cost to patients. Thus, patient standardization and comparison could not be made.
Conclusion
CE should be selected as first-line diagnostic evaluation method for patients without evidence of obstruction in tomography results who have clinically perceptible GI bleeding that recurs or persists after negative upper and lower GI tract endoscopic examination.
